Type 1 ryanodine receptor-based methods

Details for Australian Patent Application No. 2004220548 (hide)

Owner The Trustees of Columbia University, in the City of New York

Inventors Marks, Andrew R.

Agent Spruson & Ferguson

Pub. Number AU-A-2004220548

PCT Pub. Number WO2004/080283

Priority 60/452,664 07.03.03 US

Filing date 5 March 2004

Wipo publication date 23 September 2004

International Classifications

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/080283 Priority application(s): WO2004/080283

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220549-Influenza virus vaccine

2004220544-Oral insulin therapies and protocol